Glaxosmithkline | Custo De Mercadoria Vendida



Cost Of Sales Alterar Data
AbbVie USD 4B 394M 2025-03
Amgen USD 2.6B 507M 2025-03
AstraZeneca USD 2.24B 484M 2025-03
Aurora Cannabis CAD 78.85M 891K 2024-12
Bausch Health Companies USD 701M 26M 2025-03
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Canopy Growth CAD 50.66M 9.51M 2024-12
Corcept Therapeutics USD 2.4M 553K 2025-03
Drreddys Laboratories INR 34.53B 2.14B 2024-12
Eli Lilly USD 2.22B 179.6M 2025-03
GlaxoSmithKline GBP 1.92B 635M 2025-03
Glaxosmithkline GBP 2.52B 199M 2024-12
Indivior 44M 21M 2025-03
J&J USD 7.3B 189M 2025-03
Merck USD 2.76B 944M 2025-03
Novartis USD 3.32B 90M 2024-12
Pacira USD 34.31M 5.58M 2025-03
Perrigo USD 651.6M 100.8M 2025-03
Pfizer USD 2.59B 3.06B 2025-03
Prestige Brands USD 126.51M 2.76M 2025-03
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 2.89B 618M 2025-03
Supernus Pharmaceuticals USD 17.2M 385K 2024-12
Takeda JPY 382.08B 34.8B 2025-03
Teva Pharmaceutical Industries USD 1.98B 132M 2025-03
Zoetis USD 622M 85M 2025-03



Glaxosmithkline Custo De Mercadoria Vendida - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.